2 Ways to Invest in The Medical Robot Market Before it Skyrockets
- Medical researchers have created microscopic medical robots that can deliver painkillers and cancer drugs, and even clear clogged arteries.
- With the global market for all robot types projected to skyrocket 1,180% — from $39 billion 2017 to $499 billion by 2025 — here’s the best way to tap into the rise of medical minirobots for double-digit profits.
As a kid, I was captivated by the 1966 sci-fi thriller Fantastic Voyage, and not just because I had an early crush on Raquel Welch.
The film centers on a submarine crew, shrunk to microscopic size, that ventures into the body of an injured scientist to repair damage to his brain.
Fast-forward 53 years, and that sci-fi premise is becoming a sci-fact reality. In just the past three years:
- Swiss scientists have created the first biodegradable microscopic medical robots — 1,000 times smaller than the period at the end of this sentence — designed to clear clogged arteries and deliver painkillers at the cellular level.
- Researchers are testing fleets of minirobots that ferry cancer drugs to tumors inside the body.
- Engineers have created a vitamin-sized robotic “PillCam” that scans the digestive tract and is now being used in place of colonoscopies for some patients.
These are just three examples of how small robots are having a big impact on modern medicine — in ways the makers of Fantastic Voyage could never have imagined.
And this is just the beginning.
In fact, the global market for all robot types is projected to skyrocket 1,180% — from $39 billion in 2017 to $499 billion by 2025.
I believe the rise of robots large and small is going to have a massive impact on health care. But it also offers a massive investment opportunity to those who get in now.
One investment tool that taps the robotic market — identified by my colleague Amber Lancaster, director of investment research here at Banyan Hill Publishing — is already up 12% this year.
Minirobots: A “Twofer” Opportunity for Health and Wealth
Sixty years ago, California Institute of Technology physicist Richard Feynman first mused on the medical benefits of building bacteria-sized minirobots that could deliver targeted drugs.
In a 1959 lecture to the American Physical Society, he said: “It would be interesting in surgery if … you put the mechanical surgeon inside the blood vessel and it goes into the heart and ‘looks’ around. It finds out which valve is the faulty one and takes a little knife and slices it out.”
Seven years later, Fantastic Voyage brought the idea to the silver screen, with its miniaturized crew navigating a ship smaller than a red blood cell.
And 60 years on, we are finally seeing the fiction become reality.
Medical scientists are working to create a new world in medicine where patients with cancer or serious illnesses receive an injection of microscopic medical robots instead of surgery, radiation, drugs or chemo.
Already, biodegradable minirobots have been successfully tested in animals, cleaning out arteries, delivering drugs, performing biopsies and even treating tumors. Engineers are also refining systems to control these bots with magnets and remote controls.
The big break has come in just the past few years, as advances in semiconductor technology have brought medical minirobots closer to reality.
For instance, Massachusetts Institute of Technology engineers recently unveiled an origami-like robot made of a magnetic sliver. It folds up into a pill that is ingested, then unfolds inside the body. It’s about a centimeter long and is guided by external magnetic fields.
Researchers from the Swiss Federal Institute of Technology Lausanne have also created injectable minirobots that can swim, crawl and otherwise navigate through the body — mimicking the movement of bacteria — and do whatever’s needed.
But perhaps the first and most successful robotic medical device is the “PillCam” developed by Medtronic.
The vitamin-sized capsule can be swallowed and uses a tiny wireless camera to take pictures of your intestines as it moves through your digestive tract. The camera can transmit thousands of pictures to a belted recorder you wear around your waist.
The Food and Drug Administration has approved the PillCam as an alternative for patients who can’t tolerate colonoscopies. It can also be used to identify gastrointestinal bleeding, cancer or other digestive problems.
It’s not much of a stretch to imagine the PillCam being modified and miniaturized further for other diagnostic and treatment approaches.
And I believe those next steps will come sooner rather than later.
Your Best Robotic Investment Play
One way to invest in this market is to put your money into stocks of companies on the forefront of the robotics, artificial intelligence and semiconductor industries.
For example, one of our Bold Profits services features a robotics company that is up 34% since it was recommended. Another includes a semiconductor stock that has soared 96% since it was added to our model portfolio.
But here’s another way to get in on the action: Invest in an exchange-traded fund that collects robotics stocks.
The Global X Robotics & Artificial Intelligence exchange-traded fund (Nasdaq: BOTZ) is a great option.
This exchange-traded fund (ETF) tracks the performance of the Indxx Global Robotics & Artificial Intelligence Thematic Index.
And since January, it’s risen double digits.
By investing in the innovative companies leading the robotics revolution, you are not only contributing to huge med-tech advances in health, but also pocketing the profits from those innovations.
Until next week…
To your health and wealth,
Senior Editorial Manager, Banyan Hill Publishing